PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $164,000 | -2.4% | 23,303 | -2.5% | 0.09% | +335.0% |
| Q4 2019 | $168,000 | +33.3% | 23,900 | +136.6% | 0.02% | +233.3% |
| Q1 2019 | $126,000 | -80.2% | 10,100 | -89.3% | 0.01% | -86.4% |
| Q4 2018 | $636,000 | -55.5% | 94,600 | -31.8% | 0.04% | -46.3% |
| Q3 2018 | $1,428,000 | +53.7% | 138,800 | +0.4% | 0.08% | +51.9% |
| Q2 2018 | $929,000 | +32.5% | 138,300 | +69.3% | 0.05% | +20.0% |
| Q1 2018 | $701,000 | +56.8% | 81,700 | +280.0% | 0.04% | +87.5% |
| Q4 2017 | $447,000 | +10.9% | 21,500 | -31.7% | 0.02% | -4.0% |
| Q1 2017 | $403,000 | -41.8% | 31,500 | 0.0% | 0.02% | -56.1% |
| Q4 2016 | $692,000 | -22.2% | 31,500 | -25.2% | 0.06% | -20.8% |
| Q3 2016 | $889,000 | – | 42,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |